قارن الطرق

	مؤشر ويسترن أونتاريو وماكماستر للالتهاب المفصلي العظمي (WOMAC)	مقياس نتائج إعاقة الورك والفصال العظمي (HOOS)
المجال	إعادة التأهيل	إعادة التأهيل
العائلة	Process / pipeline	Process / pipeline
سنة النشأة	1988	2003
صاحب الطريقة	Bellamy, Buchanan, Goldsmith	Nilsdotter, Lohmander, Klassbo, Roos
النوع	Patient-reported outcome measure	Patient-reported outcome measure
المصدر التأسيسي	Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., & Stitt, L. W. (1988). Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Journal of Rheumatology, 15(12), 1833–1840.	Nilsdotter, A. K., Lohmander, L. S., Klassbo, M., & Roos, E. M. (2003). Hip Disability and Osteoarthritis Outcome Score (HOOS): development and validation against generic outcome measures in hip osteoarthritis. Arthritis & Rheumatism, 48(11), 3336–3345.
الأسماء البديلة	WOMAC Scale, WOMAC Arthritis Index	HOOS, HOOS Scale
ذات صلة	4	2
الملخص	The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used patient-reported outcome measure designed to assess pain, stiffness, and physical function in patients with osteoarthritis of the hip or knee. Developed by Bellamy and colleagues in 1988, it has become the gold standard outcome measure in osteoarthritis clinical trials and practice.	The Hip Disability and Osteoarthritis Outcome Score (HOOS) is a patient-reported outcome measure developed to assess pain, symptoms, function, and quality of life in patients with hip osteoarthritis and hip disability. Developed by Nilsdotter and colleagues in 2003, HOOS parallels the structure of KOOS (Knee Injury and Osteoarthritis Outcome Score) but is specifically tailored for the hip joint, making it the reference standard for hip osteoarthritis outcomes in clinical trials and practice.